Professor Miles Witham
Victoria Bartle
Dr Sue Bellass
Dr Jonny Bunn
Professor Heather Cordell
et al. | Building ADMISSION – a research collaborative to transform understanding of multiple long-term conditions for people admitted to hospital | 2025 |
|
Dr Chris Plummer
Professor Avan Sayer
Professor Miles Witham
| How far back do we need to look to capture diagnoses in electronic health records? A retrospective observational study of hospital electronic health record data | 2024 |
|
Dr David Austin
Rebecca Maier
Dr Nicola Cresti
Dr Mark Verrill
Dr Wendy Osborne
et al. | Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial | 2024 |
|
Dr Chris Plummer
| Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee | 2024 |
|
Professor Gareth Veal
Professor Steve Wedge
Dr Christopher Bacon
Professor Philip Sloan
Professor Alastair Greystoke
et al. | A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer | 2023 |
|
Dr Dan Weiand
Dr Chris Plummer
| Impact of computerised provider order entry on the quality and quantity of clinical information included with investigation requests: an interrupted time series analysis | 2023 |
|
Professor Roderick Skinner
Dr Chris Plummer
| Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group | 2023 |
|
Dr Chris Plummer
Professor Roderick Skinner
| Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group | 2021 |
|
Dr Chris Plummer
| Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: The PERSEPHONE non-inferiority RCT | 2020 |
|
Dr Chris Plummer
| 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial | 2019 |
|
Dr Chris Plummer
| Behind the scenes of the European Examination in General Cardiology | 2019 |
|
Dr Simon Findlay
Dr Jason Gill
Professor Ruth Plummer
Carol De Santis
Dr Chris Plummer
et al. | Chronic cardiovascular toxicity in the older oncology patient population | 2019 |
|
Dr Chris Plummer
| How to succeed in the EEGC: A guide for trainees and their trainers | 2019 |
|
Dr Chris Plummer
| A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial | 2018 |
|
Dr Chris Plummer
| Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure | 2016 |
|
Professor Neil Rajan
Paul Hainsworth
Peter Hodgkinson
Dr Piotr Pieniazek
Dr Chris Plummer
et al. | Mesenteric cysts in naevoid basal cell carcinoma syndrome: A mimic of metastatic disease | 2016 |
|
Dr Chris Plummer
| Individual patient data network meta-analysis of mortality effects of implantable cardiac devices | 2015 |
|
Dr Chris Plummer
| Safe use of MRI in people with cardiac implantable electronic devices | 2015 |
|
S Clark
Dr Chris Plummer
| Unusual cause of hypoxemia after automatic implantable cardioverter-defibrillatorleads extraction | 2015 |
|
Dr Iftikhar Fazal
Dr Chris Plummer
Dr Janet McComb
| Remote vs. conventional follow-up of implantable loop recorders; time to diagnosis and overall diagnostic yield is similar | 2014 |
|
Dr Fareeda Coxon
Dr Chris Plummer
| Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report | 2013 |
|
Dr Nicola Cresti
Dr Chris Plummer
| Cardiac troponin release following standard dose anthracycline-based adjuvant chemotherapy | 2013 |
|
Dr Iftikhar Fazal
Dr Ewan Shepherd
Dr Chris Plummer
Dr Janet McComb
| Comparison of Sprint Fidelis and Riata defibrillator lead failure rates | 2013 |
|
Dr Iain Matthews
Dr Chris Plummer
Dr Steve Parry
| Positive versus Negative Adenosine Tests in Unexplained Syncope Presenting to Acute Medical Services | 2013 |
|
Dr Iftikhar Fazal
Rashmi Bhardwaj
Dr Chris Plummer
Dr Janet McComb
| Remote monitoring of implantable loop recorders: high artefact in the early phase following implant | 2012 |
|
Dr Chris Plummer
Dr Mark Verrill
| Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials | 2010 |
|
Dr Chris Plummer
Dr Mark Verrill
| Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk | 2009 |
|
Dr Mark Verrill
Dr Chris Plummer
| DEVELOPMENT AND IMPLEMENTATION OF NEW UK NATIONAL CANCER RESEARCH INSTITUTE (NCRI) GUIDELINES FOR PREVENTING AND MANAGING CARDIAC EVENTS WITH TRASTUZUMAB | 2008 |
|
Dr Chris Plummer
Dr Janet McComb
| An audit of pacing practice in the 33 cardiac networks serving England and Wales | 2007 |
|
Dr Michael Cunnington
Dr Chris Plummer
Dr Janet McComb
| Delays to permanent pacemaker implantation: An explanation for low implantation rates in the United Kingdom? | 2007 |
|
Dr Janet McComb
Dr Chris Plummer
Dr Ruth Charles
| Inequity of access to cardiac pacing: Results of a national survey | 2007 |
|
Dr Janet McComb
Dr Chris Plummer
| Lack of knowledge of pacemaker indications at the front line | 2007 |
|
Dr Janet McComb
Dr Chris Plummer
| Recognition of ecg abnormalities associated with atrioventricular conduction defects | 2007 |
|
Dr Chris Plummer
| Implications of national guidance on pacing mode in the UK | 2006 |
|
Dr Janet McComb
Dr Chris Plummer
| Inequity of access to pacemaker implantation for bradycardia in England | 2006 |
|
Dr Chris Plummer
| What's in the CARDS? | 2006 |
|
Dr Rodney Bexton
Dr Chris Plummer
Professor John Dark
Dr Fiona Black
Dr James Lordan
et al. | Aortic regurgitation and Churg-Strauss syndrome | 2005 |
|
Dr Chris Plummer
Dr Janet McComb
| The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002 | 2005 |
|
Dr Chris Plummer
Dr Janet McComb
| The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district | 2005 |
|
Dr Ewan Shepherd
Dr Chris Plummer
Professor Azfar Zaman
Dr Janet McComb
| Mortality and symptom benefit with cardiac resynchronisation therapy (CRT) in severe heart failure | 2004 |
|
Dr Chris Plummer
Dr Janet McComb
| An audit of the implications of implementing NICE guidance on the use of implantable cardioverter-defibrillators | 2003 |
|
Dr Chris Plummer
Dr Janet McComb
| Detection of atrial fibrillation by permanent pacemakers: observations from the STOP AF trial | 2003 |
|
Dr Chris Plummer
Dr Janet McComb
Dr Rodney Bexton
| Impact of district hospital pacing centres on regional pacemaker implantation rates | 2003 |
|
Dr Chris Plummer
Dr Janet McComb
| Impact of nice guidance on implantable cardioverter defibrillator (ICD) implantation an audit of ICD indications in a tertiary centre and a district hospital | 2003 |
|
Dr Chris Plummer
Dr Janet McComb
| Implications of national guidance for implantable cardioverter deibrillation implantation in the United Kingdom | 2003 |
|
Dr Chris Plummer
Dr Janet McComb
| Implications of national guidance on the implantation of implantable cardioverter-defibrillators for arrhythmias | 2002 |
|
Dr Chris Plummer
Dr Janet McComb
| Audit of potential implantable cardioverter defibrillator patients | 2001 |
|
Dr Chris Plummer
Dr Janet McComb
| The use of permanent pacemakers in the detection of cardiac arrhythmias | 2001 |
|
Dr Chris Plummer
Dr Janet McComb
| Tachy-brady syndrome six years after cardiac transplantation | 1999 |
|
